One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets
Alia Mushtaq a , Peng Wu b , Muhammad Moazzam Naseer
doi : 10.1016/j.pharmthera.2023.108579
Volume 254, February 2024, 108579
CDNF and ER stress: Pharmacology and therapeutic possibilities
Helike L?helaid a,c , Mart Saarma b , Mikko Airavaara
doi : 10.1016/j.pharmthera.2024.108594
Volume 254, February 2024, 108594
A novel therapeutic target for kidney diseases: Lessons learned from starvation response
Kosuke Yamahara, Mako Yasuda-Yamahara, Shinji Kume
doi : 10.1016/j.pharmthera.2024.108590
Volume 254, February 2024, 108590
Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective
Zhi Yang a,1 , Fada Guan b,1 , Lawrence Bronk c , Lina Zhao
doi : 10.1016/j.pharmthera.2024.108591
Volume 254, February 2024, 108591
Berberine prevents NAFLD and HCC by modulating metabolic disorders
Xinyue Lin a , Juanhong Zhang a,b , Yajun Chu a , Qiuying Nie a , Junmin Zhang
doi : 10.1016/j.pharmthera.2024.108593
Volume 254, February 2024, 108593
Olea europaea L-derived secoiridoids: Beneficial health effects and potential therapeutic approaches
Simone Filardo a,1 , Mattioli Roberto b,1 , Daniel Di Risola b , Luciana Mosca b , Marisa Di Pietro a,2 , Rosa Sessa
doi : 10.1016/j.pharmthera.2024.108595
Volume 254, February 2024, 108595
Transformation or replacement - Effects of hormone therapy on cardiovascular risk
Julia Kielb a,c,?, Süreyya Saffak a,c,?, Jessica Weber a,c , Leonard Baensch a,c , Khatereh Shahjerdi a,c , Aylin Celik a,c , Nora Farahat a,c , Sally Riek a,c , Oscar Chavez-Talavera a,c , Maria Grandoch b , Amin Polzin a,c , Malte Kelm a,c , Lisa Dannenberg
doi : 10.1016/j.pharmthera.2024.108592
Volume 254, February 2024, 108592
